Literature DB >> 8333540

Transepithelial transport of cholyltaurine by Caco-2 cell monolayers is sodium dependent.

C E Chandler1, L M Zaccaro, J B Moberly.   

Abstract

Bile acids are efficiently recovered from the intestinal lumen by a Na(+)-dependent transport process that is localized in the ileal enterocyte brush-border membrane. To establish a cell culture model for this process, we examined the Na+ dependence of cholyltaurine (C-tau; taurocholate) transport across monolayers of differentiated Caco-2 cells grown on permeable filter inserts. Transport of [3H]C-tau was Na+ dependent (> 20-fold stimulation), saturable, and time linear for at least 60 min. The apparent Michaelis constant of [3H]C-tau transport was approximately 65 microM, and the maximal transport rate was approximately 800 pmol.min-1.mg protein-1. Transport of [3H]C-tau in the apical-to-basolateral direction was 17-fold greater than transport in the reverse direction. Lowered incubation temperature, various metabolic inhibitors, and various unlabeled bile acids inhibited [3H]C-tau transport. Caco-2 cells thus transport bile acids in a manner similar to that described for ileal brush-border membrane vesicles and isolated ileal enterocytes and are therefore an appropriate model for studying the molecular basis of ileal bile acid transport.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8333540     DOI: 10.1152/ajpgi.1993.264.6.G1118

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism.

Authors:  Paul A Dawson; Melissa L Hubbert; Anuradha Rao
Journal:  Biochim Biophys Acta       Date:  2010-06-09

2.  Evidence for diminished functional expression of intestinal transporters in Caco-2 cell monolayers at high passages.

Authors:  H Yu; T J Cook; P J Sinko
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

3.  Regulation of expression of human intestinal bile acid-binding protein in Caco-2 cells.

Authors:  T Kanda; L Foucand; Y Nakamura; I Niot; P Besnard; M Fujita; Y Sakai; K Hatakeyama; T Ono; H Fujii
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

4.  In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man--fact or myth.

Authors:  S Yee
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

5.  Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation.

Authors:  Anand Balakrishnan; Stephen A Wring; James E Polli
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

6.  Rat cholangiocytes absorb bile acids at their apical domain via the ileal sodium-dependent bile acid transporter.

Authors:  K N Lazaridis; L Pham; P Tietz; R A Marinelli; P C deGroen; S Levine; P A Dawson; N F LaRusso
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

7.  Use of the intestinal bile acid transporter for the uptake of cholic acid conjugates with HIV-1 protease inhibitory activity.

Authors:  M Kågedahl; P W Swaan; C T Redemann; M Tang; C S Craik; F C Szoka; S Oie
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

Review 8.  Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target.

Authors:  Anand Balakrishnan; James E Polli
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

9.  Development of stably transfected monolayer overexpressing the human apical sodium-dependent bile acid transporter (hASBT).

Authors:  Anand Balakrishnan; Daniel J Sussman; James E Polli
Journal:  Pharm Res       Date:  2005-08-03       Impact factor: 4.200

10.  Characterization of the uptake mechanism for a novel loop diuretic, M17055, in Caco-2 cells: involvement of organic anion transporting polypeptide (OATP)-B.

Authors:  Tomohiro Nishimura; Yoshiyuki Kubo; Yukio Kato; Yoshimichi Sai; Takuo Ogihara; Akira Tsuji
Journal:  Pharm Res       Date:  2006-11-14       Impact factor: 4.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.